Introduction: OnabotulinumtoxinA (onabotA) is approved for treatment of post-stroke upper limb spasticity (PSULS) at a maximum dose of 400U across elbow, wrist, and finger sites. Safety and efficacy ...

C7 neurotomy added to standard speech therapy enhances language recovery in patients with chronic post-stroke aphasia, a randomized trial suggests.